Patch-clamp evidence for calcium channels in apical membranes of rabbit kidney connecting tubules.
To test the hypothesis that Ca channel plays a role in renal epithelial Ca transport, we exposed and patched apical membranes of freshly microdissected rabbit connecting tubules (CNTs). Single channel Ca currents were recorded with Ba as the charge carrier. In the cell-attached mode, 8-Br-cAMP increased the open-state probability (Po) to 0.6%. In excised, inside-out patches, Po was low spontaneously and remained low during either bath protein kinase A catalytic subunit (PKAcs) or Bay K 8644. Exposure to both agonists, however, unmasked Ca channels previously latent with only one, raising Po by 1.05% at membrane potential of -70 mV. Mean Po for 14 seals (2.57%) peaked at -70 mV, declining with either hyperpolarization or depolarization. The slope conductance was 25 pS. The extrapolated reversal potential (138 mV) agrees with the calculated equilibrium potential for Ca (158 mV). The Ca to Na permeability ratio exceeded 2,800. In four patches stimulated by Bay K 8644 and PKAcs, bath nifedipine reduced Po from 1.03 to 0.15% at -63 mV. These patch-clamp data demonstrate a selective, 25-pS, cAMP/PKAcs-sensitive Ca channel in apical membranes of CNT. Po is stimulated by PKAcs and dihydropyridine (DHP) agonist, but inhibited by DHP antagonist and by depolarization. The data are consistent with the potential role of apical membrane Ca channel in epithelial Ca transport.
Tan
S
S
Department of Medicine, University of Oklahoma, Oklahoma City.
Lau
K
K
D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / Q000494:pharmacology; D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D015220:Calcium Channels / Q000187:drug effects / Q000502:physiology*; D002462:Cell Membrane / Q000502:physiology*; D017868:Cyclic AMP-Dependent Protein Kinases / Q000494:pharmacology; D004594:Electrophysiology / Q000379:methods; D004848:Epithelium / Q000502:physiology; D066298:In Vitro Techniques; D015640:Ion Channel Gating; D007684:Kidney Tubules / Q000502:physiology*; D046911:Macromolecular Substances; D008564:Membrane Potentials / Q000187:drug effects; D009543:Nifedipine / Q000494:pharmacology; D011817:Rabbits
D015220:Calcium Channels; D046911:Macromolecular Substances; D015124:8-Bromo Cyclic Adenosine Monophosphate; D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; D000255:Adenosine Triphosphate; D017868:Cyclic AMP-Dependent Protein Kinases; D009543:Nifedipine